ABclonal
PrivateLast Round
Series D
Dec 8, 2021
Total Funding Raised
$284.02M
Company Overview
ABclonal is a biotechnology company that manufactures life science reagents, including antibodies, recombinant proteins, ELISA kits, and molecular biology enzymes, while providing contract research organization (CRO) services for scientific research and diagnostic applications.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Biotech Equipment, Drug Discovery
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ABclonal Comparables
Compare ABclonal with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Cell Signaling Technology | 83% | |
| Sino Biological Inc. | 83% | |
| Proteintech Group | 82% | |
ABclonal Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series D | Dec 8, 2021 | ||||
| Series C | Feb 22, 2021 | ||||
| Series B | Aug 1, 2016 | ||||
| Series A | Mar 1, 2016 |
ABclonal Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Loyal Valley Capital | Series D |
| Oriza FOFs | Series C |
| LYFE Capital | Series C |
| C&D Emerging Industry Equity Investment | Series C |
| Beijing Taikang Investment Management Co., Ltd. | Series D |
| Sigma Square Capital | Series C |
| HongShan Capital Group (HSG) | Series D, Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 22, 2021
$93M round led by LYFE Capital and HongShan.
ABclonal Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about ABclonal's valuation, stock price, and market status.